However, our study also addresses transcriptomic differences in circulating CD8 T cells alongside phenotypic changes, providing key insights into potential functional differences in CD8 T cells from patients with NSCLC who respond to PD-1 blockade. The gene discussed is CD8A; the disease is non-small cell lung carcinoma.